ABT-199, a BH3 mimetic that specifically targets Bcl-2,...

  • Main
  • 2015 / 01
  • ABT-199, a BH3 mimetic that specifically targets Bcl-2,...
Leukemia and Lymphoma 2015 / 01

ABT-199, a BH3 mimetic that specifically targets Bcl-2, enhances the antitumor activity of chemotherapy, bortezomib and JQ1 in “double hit” lymphoma cells

Johnson-Farley, Nadine, Veliz, Jonny, Bhagavathi, S., Bertino, Joseph R.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2014.981172
Date:
January, 2015
File:
PDF, 726 KB
english, 2015
Conversion to is in progress
Conversion to is failed